Form 4: Nuvation Bio Director Cui Xiangmin Reports Stock Purchase

Director Cui Xiangmin reports purchasing 277,895 shares of Nuvation Bio Inc. at an average price of $2.97.

Summary

• On June 25, 2024, Cui Xiangmin, a director of Nuvation Bio Inc., purchased 277,895 shares of Class A Common Stock at an average price of $2.97.
• The shares were bought in multiple transactions with prices ranging from $2.92 to $3.00.
• Following the transaction, Cui Xiangmin indirectly owns 2,453,131 shares through Decheng Capital Global Healthcare Fund (Master), LP, 314,106 shares through Decheng Capital China Life Sciences USD Fund III, L.P., and 4,183,002 shares through Decheng Anbio Limited.
• Cui Xiangmin disclaims beneficial ownership of these indirectly held securities except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director's purchase of shares can be interpreted as a sign of confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• The purchase by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company insiders, which can influence market sentiment.

Stakeholder Impact

• The stock purchase by a director may positively influence shareholder sentiment.

Key Dates